nalfurafine hydrochloride
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Pruritus is one of the complications of chronic liver disease, and it is important to investigate the predictors.
The recurrence rates of pruritus after stopping nalfurafine hydrochloride are unknown in chronic liver disease.
Introduction Chronic liver disease (CLD)-related pruritus manifests as cholestasis symptoms, which can cause severe itches in the…
Nalfurafine hydrochloride (TRK-820), which exhibits strong κ-opioid agonistic activity, has an antipruritic effect on uremic…
pharmacology history of and the frontiers of pharmacology a new world in the of drugs. New technologies and continuing progress…
Nalfurafine hydrochloride, a kappa-opioid receptor agonist, was approved in January 2009 and released to the market on March 2009…
Pruritus is a common symptom seen in 25-90% of uremic patients, especially those with chronic renal failure requiring…